Claritas Pharmaceuticals

0 followers

‌

Claritas Pharmaceuticals is developing R-107, a nitric oxide-releasing molecule designed to treat vaccine-resistant COVID-19 infection.

Industries

Headquarters

Stage

Employees

Links

Org chart

President & CEO

Robert Farrell

Collapse

Director, Business Development

Director, Quality Control

Director, Quality Assurance

Head, Chemistry

Director, Drug Development

6 members

1 members

1 members

Syneos Health

10 followers

Charlie Health

2 followers

Eli Lilly

128 followers

Omnicell

17 followers

Alnylam Pharmaceuticals

11 followers

Discover companies